Cause of death, by non-communicable diseases, ages 60+, male in OECD members
OECD members: Cause of death, by non-communicable diseases, ages 60+, male was 78.3% in 2021. ▼ Falling
Cause of death, by non-communicable diseases, ages 60+, male in OECD members, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total male deaths ages 60+.
Analysis
In 2021, cause of death, by non-communicable diseases, ages 60+, male in OECD members stood at 78.3%. That is the lowest value across all 6 years on record.
That represents a change of down 1.6% on the previous year and down 13.0% over ten years.
Over the whole period, cause of death, by non-communicable diseases, ages 60+, male in OECD members peaked at 90.4% in 2000 and was at its lowest, 78.3%, in 2021.
OECD members ranks 10th of 47 groups on this measure, in the top quarter.
Cause of death, by non-communicable diseases, ages 60+, male in OECD members, year by year
| Year | % of total male deaths ages 60+ | Change |
|---|---|---|
| 2000 | 90.4% | — |
| 2010 | 89.9% | -0.5% |
| 2015 | 89.4% | -0.6% |
| 2019 | 89.5% | +0.1% |
| 2020 | 79.5% | -11.1% |
| 2021 | 78.3% | -1.6% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 90.4% | 90.4% | 90.4% | 1 |
| 2010s | 89.6% | 89.4% | 89.9% | 3 |
| 2020s | 78.9% | 78.3% | 79.5% | 2 |
Countries ranked near OECD members
- 7 Tonga 90.4% compare
- 8 Micronesia (country) 89.4% compare
- 9 Turkmenistan 89.1% compare
- 10 Denmark 87.7% compare
- 11 Norway 87.5% compare
- 12 Canada 87.2% compare
- 13 Uzbekistan 85.9% compare
More health data for OECD members
- Population ages 40-44, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 10-14, female, annual growth rate -0.5618 % change on previous year (2025)
- Population ages 45-49, female, annual growth rate 0.5518 % change on previous year (2025)
- Population ages 40-44, male, per capita 0.0336 units per person (2025)
- Population ages 40-44, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 10-14, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 40-44, male, annual growth rate -0.0796 % change on previous year (2025)
- Population ages 40-44, female, per capita 0.0334 units per person (2025)
- Population ages 10-14, male, annual growth rate -0.5873 % change on previous year (2025)
- Population ages 35-39, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, ages 60+, male in OECD members?
- Cause of death, by non-communicable diseases, ages 60+, male in OECD members was 78.3% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, ages 60+, male recorded in OECD members?
- The highest recorded value was 90.4% in 2000.
- What is the lowest cause of death, by non-communicable diseases, ages 60+, male recorded in OECD members?
- The lowest recorded value was 78.3% in 2021.
- How does OECD members rank for cause of death, by non-communicable diseases, ages 60+, male?
- OECD members ranks 10th out of 47 groups with data for 2021.
- Is cause of death, by non-communicable diseases, ages 60+, male rising or falling in OECD members?
- Over the last ten years it is down 13.0%. The long-run trend across the full record is falling.
- Where does this OECD members data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, ages 60+, male (% of total male deaths ages 60+). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of male deaths ages 60+ due to non-communicable diseases divided by number of all male deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.